Literature DB >> 17212580

Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy.

A L Goldberg1.   

Abstract

This review focuses on recent insights into the mechanisms and the biological functions of the proteasome. This large ATP-dependent proteolytic complex is the main site for protein degradation in mammalian cells and catalyses the rapid degradation of ubiquitinated proteins, and is the source of most antigenic peptides used by the immune system to screen for viruses and cancer. ATP is required to unfold globular proteins to open the gated channel into the 20S proteasome and to facilitate protein translation into it. Inhibitors of its proteolytic activity are widely used as research tools and have proven effective in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212580     DOI: 10.1042/BST0350012

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  140 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

2.  A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

Authors:  Nawel Merzougui; Roland Kratzer; Loredana Saveanu; Peter van Endert
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

Review 3.  Twists and turns in ubiquitin-like protein conjugation cascades.

Authors:  Brenda A Schulman
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

4.  Dual functions of the Hsm3 protein in chaperoning and scaffolding regulatory particle subunits during the proteasome assembly.

Authors:  Marie-Bénédicte Barrault; Nicolas Richet; Chloe Godard; Brice Murciano; Benoît Le Tallec; Erwann Rousseau; Pierre Legrand; Jean-Baptiste Charbonnier; Marie-Hélène Le Du; Raphaël Guérois; Françoise Ochsenbein; Anne Peyroche
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-29       Impact factor: 11.205

5.  Tau toxicity feeds forward in frontotemporal dementia.

Authors:  David C Rubinsztein
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

6.  Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.

Authors:  Henry W B Johnson; Janet L Anderl; Erin K Bradley; John Bui; Jeffrey Jones; Shirin Arastu-Kapur; Lisa M Kelly; Eric Lowe; David C Moebius; Tony Muchamuel; Christopher Kirk; Zhengping Wang; Dustin McMinn
Journal:  ACS Med Chem Lett       Date:  2017-03-09       Impact factor: 4.345

7.  Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.

Authors:  Daniela B B Trivella; Alban R Pereira; Martin L Stein; Yusuke Kasai; Tara Byrum; Frederick A Valeriote; Dean J Tantillo; Michael Groll; William H Gerwick; Bradley S Moore
Journal:  Chem Biol       Date:  2014-06-12

8.  Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.

Authors:  Pradeep K Singh; Hao Fan; Xiuju Jiang; Lei Shi; Carl F Nathan; Gang Lin
Journal:  ChemMedChem       Date:  2016-08-25       Impact factor: 3.466

9.  Cell biology: The proteasome assembly line.

Authors:  Kiran Madura
Journal:  Nature       Date:  2009-06-11       Impact factor: 49.962

10.  Multiple assembly chaperones govern biogenesis of the proteasome regulatory particle base.

Authors:  Minoru Funakoshi; Robert J Tomko; Hideki Kobayashi; Mark Hochstrasser
Journal:  Cell       Date:  2009-05-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.